Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis


Kalincik T., Havrdova E. K. , Horakova D., Izquierdo G., Prat A., Girard M., ...Daha Fazla

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, cilt.90, ss.458-468, 2019 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 90 Konu: 4
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1136/jnnp-2018-319831
  • Dergi Adı: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
  • Sayfa Sayıları: ss.458-468

Özet

Objective Oral immunotherapies have become a standard treatment in relapsing-remitting multiple sclerosis. Direct comparison of their effect on relapse and disability is needed.